Investor s Fiduciary Advisor Network LLC Invests $1.20 Million in Danaher Co. (NYSE:DHR)

Investor s Fiduciary Advisor Network LLC acquired a new stake in Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,217 shares of the conglomerate's stock, valued at approximately $1,197,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Norges Bank acquired a new stake in shares of Danaher during the 4th quarter worth approximately $2,130,740,000. Raymond James Financial Inc. acquired a new stake in Danaher during the fourth quarter worth $391,172,000. Capital World Investors raised its position in Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares during the period. Northern Trust Corp lifted its stake in shares of Danaher by 14.3% in the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after purchasing an additional 992,594 shares during the last quarter. Finally, Van ECK Associates Corp grew its holdings in shares of Danaher by 6,862.7% during the 4th quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate's stock worth $213,452,000 after purchasing an additional 916,513 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DHR has been the topic of a number of recent analyst reports. Barclays upped their target price on shares of Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a report on Friday, March 14th. UBS Group lowered their price target on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. cut their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $264.40.

Danaher Price Performance

Shares of NYSE DHR opened at $189.42 on Friday. The stock's 50-day simple moving average is $198.39 and its 200-day simple moving average is $219.21. The firm has a market capitalization of $135.56 billion, a PE ratio of 35.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. As a group, equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher's dividend payout ratio is presently 24.85%.

Insiders Place Their Bets

In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.